BioLife Solutions, Inc.
BLFS
$20.12
-$0.55-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 136.47% | -- | 95.62% | 183.30% |
| Total Depreciation and Amortization | -- | -42.38% | -- | -39.24% | 174.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 31.87% | -- | -25.45% | -194.28% |
| Change in Net Operating Assets | -- | -144.20% | -- | -42.55% | -84.02% |
| Cash from Operations | -- | 27.11% | 14.07% | 138.59% | -28.82% |
| Capital Expenditure | -- | -137.40% | -- | 48.17% | 66.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1,623.31% | -- | -4,565.94% | 1,073.93% |
| Cash from Investing | -- | -254.97% | -194.25% | -12,196.83% | 1,760.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 7.89% | -- | -937.34% | -1,951.89% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -99.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -103.56% | -- | 30.80% | 0.00% |
| Cash from Financing | -- | -145.73% | -308.81% | -214.29% | -141.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -53.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -214.41% | -356.29% | -397.83% | 340.42% |